| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 18 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 569.5K | $30.19M | - | |
| CFO | 103.2K | $5.47M | - | |
| Other | 72.3K | $3.83M | - | |
| Other | 67.2K | $3.56M | - | |
| Other | 64.3K | $3.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2019 | Vivo Ventures V, LLC | 10% Owner | Sell | 34,028 | $1.62 | $55,125.36 | -0.9% | |
| Nov 27, 2019 | Vivo Ventures V, LLC | 10% Owner | Sell | 18,069 | $1.55 | $27,948.99 | -0.2% | |
| Nov 25, 2019 | Vivo Ventures V, LLC | 10% Owner | Sell | 61,671 | $1.55 | $95,737.80 | -0.6% | |
| Nov 20, 2019 | Vivo Ventures V, LLC | 10% Owner | Sell | 41,629 | $1.55 | $64,524.95 | -0.4% | |
| Nov 19, 2019 | Melincoff Gwen A | Director | Buy | 10,000 | $1.54 | $15,364.00 | New | |
| Nov 15, 2019 | Vivo Ventures V, LLC | 10% Owner | Sell | 97,024 | $1.55 | $150,387.20 | -0.8% | |
| Nov 5, 2019 | Vivo Ventures V, LLC | 10% Owner | Sell | 8,764 | $1.55 | $13,584.20 | -0.2% | |
| Nov 4, 2019 | Vivo Ventures V, LLC | 10% Owner | Sell | 334,417 | $1.57 | $524,786.81 | -2.7% | |
| Oct 28, 2019 | Vivo Ventures V, LLC | 10% Owner | Sell | 30,547 | $1.59 | $48,513.95 | -0.4% | |
| Oct 25, 2019 | Sinclair Andrew | Director | Buy | 2,300,000 | $1.20 | $2,760,000.00 | +49.3% |